Ethanol decreases nocturnal plasma levels of atrial natriuretic peptide (ANP 99-126) but not the N-terminal fragment of pro-atrial natriuretic peptide (ANP 1-98) in man
Ekman, A.C.; Vakkuri, O.; Vuolteenaho, O.; Leppäluoto, J.
Clinical Science 86(3): 285-290
1994
ISSN/ISBN: 0143-5221 PMID: 8156739 DOI: 10.1042/cs0860285
Accession: 008627944
1. The aim of this study was to elucidate the role of atrial natriuretic peptides in the regulation of water and electrolyte balance after alcohol intake. To this end we measured the plasma concentrations of ethanol, atrial natriuretic peptide 99-126 and the N-terminal fragment of pro-atrial natriuretic peptide (atrial natriuretic peptide 1-98), serum osmolality and serum sodium concentration, and urine output, urine osmolality and urinary sodium excretion for 12 h after administration of ethanol (0, 0.5 and 1.0 g body weight/kg) and placebo drinks to nine healthy subjects according to a double-blind cross-over design. 2.
Full Text Article emailed within 0-6 h: $19.90
Related References
Ekman, A.C.; Vakkuri, O.; Vuolteenaho, O.; Leppaluoto, J. 1994: Ethanol decreases nocturnal plasma levels of atrial natriuretic peptide (ANP 99-126) but not the N-terminal fragment of pro-atrial natriuretic peptide (ANP I-98) in man Clinical Science (1979) 86(3): 285-290Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide Clinical Science 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma : investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science (1979) 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; MacGregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science 87(3): 311-317
Pelkonen, M.; Luodonpää, M.; Vuolteenaho, O.; Pasanen, M.; Ruskoaho, H. 1996: Cocaine increases circulating levels of atrial natriuretic peptide and pro atrial natriuretic peptide N-terminal fragment in conscious rats European Journal of Pharmacology 304(1-3): 55-62
Nishikimi, T.; Mori, Y.; Ishimura, K.; Tadokoro, K.; Yagi, H.; Yabe, A.; Horinaka, S.; Matsuoka, H. 2004: Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function American Journal of Medicine 116(8): 517-523
Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; MacGregor, G.A. 1989: Immunoreactive N -terminal Pro-Atrial Natriuretic Peptide in Human Plasma: Plasma Levels and Comparisons with -Human Atrial Natriuretic Peptide in Normal Subjects, Patients with Essential Hypertension, Cardiac Transplant and Chronic Renal Failure Clinical Science 77(5): 573-579
Bucklay, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A. 1989: Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with α-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure Clinical Science (1979) 77(5): 573-579
Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.; MacGregor, G.A. 1989: Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Bruckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A. 1989: Immunoreactive amino terminal pro atrial natriuretic peptide in human plasma plasma levels and comparisons with alpha human atrial natriuretic peptide in normal subjects patients with essential hypertension cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Omland, T.; Aakvaag, A.; Bonarjee, V.V.S.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.T.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction : Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Omland, T.; Aakvaag, A.; Bonarjee, V.V.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Prontera, C.; Emdin, M.; Zucchelli, G.C.; Ripoli, A.; Passino, C.; Clerico, A. 2004: Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide Clinical Chemistry and Laboratory Medicine 42(1): 37-44
Nishikimi, T.; Matsuoka, H. 2004: Are plasma levels of atrial natriuretic peptide, N-terminal ProANP, and brain natriuretic peptide affected by the presence of coronary artery disease? Circulation 109(25): E331; Author Reply E331
Daggubati, S.; Parks, J.R.; Overton, R.M.; Cintron, G.; Schocken, D.D.; Vesely, D.L. 1997: Comparison of atrial natriuretic peptide, brain natriuretic peptide, C-natriuretic peptide, adrenomedullin, N-terminal proatrial and probrain natriuretic peptides as indicators of early congestive heart failure Journal of Investigative Medicine 45(3): 211A
Boomsma, F.; Bhaggoe, U.M.; Man in 't Veld, A.J.; Schalekamp, M.A. 1996: Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits Clinica Chimica Acta; International Journal of Clinical Chemistry 252(1): 41-49
Chang, I.C.Y.; Chen, L.Y.; Chong, J.P.C.; Austin, E.; Quay, C.N.; Gong, L.; Mark Richards, A.; Ling, L.H. 2015: Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation International Journal of Cardiology 188: 10-12
Honkonen, E.L.; Kaukinen, L.; Pehkonen, E.J.; Kaukinen, S. 1997: Atrial natriuretic peptide and N-terminal atrial natriuretic peptide in plasma reflect right ventricular volumes following coronary artery surgery Acta Anaesthesiologica Scandinavica 41(6): 685-693
Hülsmann, M.; Berger, R.; Mörtl, D.; Gore, O.; Meyer, B.; Pacher, R. 2005: Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide European Journal of Heart Failure 7(4): 552-556
Gordon, R.D.; Tunny, T.J.; Klemm, S.A.; Hamlet, S.M. 1986: Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(6): S555-S558